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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S152study ,using the cell culturing technology, was to observe what different
results would come out from the MTTassay of the ATDC5 cell proliferation,
whick had been cultured with different concentration E2.
Methods: The 17-bestradiol we use was ordered from Sigma co. and the
ATDC5 cell line was form the Riken cell bank. We culture the ATDC5
24 hours in the media with different concentration 17-bestradiol, then we
test the OD value of the different cells in MTT assay to assume the prolif-
eration of the ATDC5.
Results: After culturing 24 hours in the media with different concen-
tration 17-bestradiol, the proliferation of the ATDC5 in different
concentration 17-bestradiol were different signiﬁcantly, the higher of the
concentration, the higher of the proliferation, as follows: beside the
10-11M against 0 M, the 10-10,10-9,10-8 and 10-7 M have signiﬁcant
difference in stimulating the proliferation of ATDC5 against 0 M. between
the different concentration groups, only 10-8 M has signiﬁcant difference
against 10-11,10-10 M.
Conclusions: First, 17-bestradiol has stimulation on the proliferation of
ATDC5.
Second, 10-8 M concentration of 17-bestradiol has the strongest stimu-
lating effect than the other concentration of 17-bestradiol.
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Purpose: Total hip replacement (THR) is a successful surgical intervention,
providing relief from pain, increasingmobility and improving quality of life
for majority of patients. Within the literature some, but not all studies,
have found that obesity is associated with worse patient reported
outcomes (PROMs) of THR, and there is increasing concern that obesity
may be used as a barrier to accessing surgery.
Methods: We obtained information from 4 prospective cohort studies of
patients receiving primary THR for osteoarthritis (OA): Exeter Primary
Outcomes Study (EPOS) (n¼1589); EUROHIP (n¼908); South West London
Elective Orthopaedic Centre (SWLEOC) (n¼1523); and St. Helier (n¼799).
The primary outcome was the 12 month Oxford Hip Score (OHS) which is
used to assess pain and function.For the EUROHIP study, we imputed the
OHS from WOMAC scores using truncated regression. Confounding vari-
ables included: age, sex, SF-36 mental health, comorbidities, ﬁxed ﬂexion,
analgesic use, college education, OA in other joints, expectation of less
pain, radiographic K&L grade, ASA grade, years of hip pain, deprivation.
Each study collected data on a different set of confounders; only age and
sex were available in all 4 cohorts. Linear regression (ANCOVA) is used to
describe the association of BMI on the 12 month OHS, adjusting for the
pre-operative OHS. Multiple imputation methods were used to handle
missing data. In order to combine data across the 4 studies we used two
methodological approaches:
a) Meta-Analysis - For each study, separate models are built to describe the
association of BMI on outcome. Models are adjusted only for age and sex in
order to construct related hypotheses in each study. Fixed effects meta-
analysis is used to combine the results;
b) Combining studies - Data from all 4 studies are combined using multiple
imputation methods to impute data on missing confounders, allowing the
association of BMI on outcome to be adjusted for all potential confounders.
Results: a) Meta-Analysis - Adjusting for age and sex, for a 5 unit increase
in BMI, the 12 month OHS decreases by 0.81 95%CI (0.55 - 1.08) units
(Figure 1);Ă
b) Combining Studies - Adjusting for age and sex alone, for a 5 unit increase
in BMI, the 12 month OHS decreases by 0.72 (0.46 - 0.99) units. Adjusting
for all potential confounders, the effect is attenuated to 0.51 (0.09 - 0.92).
Hence, for each 5 unit increase in BMI, the difference in post-op OHS
becomes larger and more important. For example, compared to people
with a normal BMI (20 - 25), those in the morbidly obese group (BMI 35 -
40) would have a post-op OHS that is 1.53 units lower. However, there is
a substantial improvement in OHS after THR across all BMI groups, which
greatly outweighs any difference in post-op score (Figure 2).
Ă
Conclusions: This study provides a comprehensive assessment of the
association of BMI on PROMs of THR. Its strength lies in the 4 large
prospective cohorts of patients used to assess THR outcome, and the use of
multiple imputation methods that allowed us to adjust for a wide range of
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S153potential confounders. Moreover, the two different methods both gave
consistent results suggesting a small effect where higher BMI is associated
with worse outcomes. However, whilst the difference in 12 month OHS is
statistically signiﬁcant, these patients still receive substantial beneﬁt from
surgery, regardless of their pre-operative BMI. The ﬁndings suggest BMI
should not present a barrier to access THR in terms of PROMs.
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Purpose: While it is assumed that knee replacement surgery (KR) allows
a person to participate more fully in their desired daily activities, little
research has explored outcomes of participation in this population. While
w20% of adults > 65 years old report restrictions in activities outside the
home such as shopping or visiting, this is currently unknown among those
post-KR. Given the critical importance of participation to one's health and
the climbing rates of KR, we sought to explore the proportions of those
with restricted participation prior to and post-KR, and to determine
potential demographic and clinical factors that may be associated with
participation restrictions in this population.
Methods: The Multicenter Osteoarthritis (MOST) Study is a NIH-funded
longitudinal cohort study of 3,026 older persons with/at high risk of
developing knee osteoarthritis at the time of enrollment. The Late Life
Disability Instrument, Instrumental Limitation subscale (LLDI-IL), admin-
istered at each study visit (0, 30, and 60 months), was used to ascertain
participation. Participation restriction was deﬁned using a previously
established cut-point of < 67.6/100, with lower scores indicating more
restriction. Subjects with KR following enrollment and LLDI-IL data at least
1 year post-KR were included.
We determined the proportion of subjects with participation restrictions
overall and stratiﬁed by sex, race, and age at KR for the visit prior to KR and
 1 or  2 years post-KR. We analyzed differences between the propor-
tions prior to and 1 year using the McNemar test. We evaluated the odds
of having participation restrictions  1 year post-KR for the following
independent variables: demographic (sex, race, age at KR, educational
attainment), and clinical (depressive symptoms 16 on CES-D, quadriceps
strength, WOMAC pain severity in the KR or contralateral knee 10/20, #
of knees replaced, body mass index  30, pre-KR WOMAC physical func-
tion, and # of comorbidities) using logistic regression. Data on demo-
graphic and clinical factors were collected at the same clinic visit as the
LLDI-IL.
Results: Therewere 218 subjects with a KR between enrollment and the 60
month visit and who had LLDI-IL data  1 year post-KR, of which 160 also
had LLDI-IL data  2 years post-KR. They included 70% women, 87%
Whites; with a baseline mean age of 64.8 (SD 7.4) and mean BMI of 33.
There was a decline in the proportion with participation restrictions from
pre-KR to 1 year post-KR for all groups, reaching statistical signiﬁcance
among the youngest subjects, while the oldest experienced an increase in
the proportion with participation restriction (Table 1).
There were increased odds of participation restrictions for those with
higher depressive symptoms than those with lower (adj. OR 4.5 (2.0, 10.3)
and among those with at least moderate pain in the KR or contralateral
knee compared to those with no or less pain (adj. OR 7.0 (2.2, 22.7) and 5.3
(1.6, 16.9) respectively). There were non-signiﬁcant associations of Non-
White race and older age with participation restrictions (Table 2).
Conclusions: Although the proportions of persons with participation
restrictions decreased following KR among most demographic groups,
they continue to be much higher than the general population. While
factors such as sex, comorbidities, and strength were not associated with
participation restriction, high depressive symptoms and pain in either
knee appear to be important factors associated with this restriction. As the
rate of KR is continuing to rise dramatically, along with a growing recog-
nition that participation is an important KR patient outcome, there is
a need for further studies on risk factors for participation restrictions.Ă
Ă
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MORTALITY IN OSTEOARTHRITIS PATIENTS CONSULTING HEALTH CARE
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Purpose: Metabolic factors such as obesity play a role in the etiology of
osteoarthritis. A connection between osteoarthritis (OA), metabolical
syndrome and subsequently mortality has been suggested. Evidence
concerning mortality has unfortunately been controversial, we therefore
sought to examine the occurrence of mortality in our OA cohorts.
Methods: 384 patients were included in the ‘Genetics ARthrosis and
Progression’ (GARP) study, a prospective longitudinal cohort, with symp-
tomatic OA at multiple sites in the hand or in at least 2 of the following
sites: hand, knee, hip or spine. Patients consulted rheumatologists,
orthopedic surgeons or general practitioners and underwent baseline
assessment between August 2000 and March 2003.
For the replication analysis, we studied 460 patients who consulted the
rheumatology outpatient clinic and the clinical nurse specialist. They were
consecutively included in the ‘Zorgpad artrose’ cohort between August
